CMS leaves reimbursement for home hemodialysis largely unchanged. |
|
|
Mass Device: The Centers for Medicare & Medicaid leave the home hemodialysis rule as it is, dashing some analysts' hopes of improved reimbursement status and a near-term upside for NxStage Medical.
|